Kairos Pharma issues investor presentation for LD Micro Invitational; no material new data disclosed

Kairos Pharma, LTD.

Company issued investor presentation for presentation at LD Micro Invitational on May 18-19, 2026.
CEO John Yu will present update on clinical program and partnering activities.
No specific financial results, milestones, or clinical data endpoints provided in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.